Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03419858 · ClinicalTrials.gov registry record · Early Phase 1

The Role of Opioidergic Systems in Breathing Based Analgesia

A Early Phase 1 study of Pain, sponsored by University of California, San Diego.

Completed
Registry status
Early Phase 1
Development phase
60
Enrollment target
1
Study location

NCT03419858: Completed Early Phase 1 study of Pain, sponsored by University of California, San Diego.

NCT03419858 is a Early Phase 1 study of Pain that has completed, run by University of California, San Diego. The registered enrollment target is 60 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03419858, a Early Phase 1 study of Pain, has completed, sponsored by University of California, San Diego.

COMPLETED
Registry status
Early Phase 1
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The purpose of this psychophysical and pharmacologic study is to determine if slow-breathing induced pain relief is mediated by endogenous opioids in response to intravenous (IV) administration of the opioid antagonist naloxone during noxious heat stimulation. We were also interested in disentangling the endogenous analgesic mechanisms supporting mindfulness-based analgesia.

Primary Outcome

The visual analog scale (VAS) measures pain ratings that are assessed in response to noxious (49°C) thermal stimuli applied to the back of the right calf muscle. Pain intensity and unpleasantness ratings will be assessed with a Visual Analog Scale. The minimum rating ("0") is designated as "no pain" whereas the maximum ("10") is labeled as "most intense imaginable" or "most unpleasant imaginable". Higher values corresponded to higher perceived pain ratings. Pain ratings were assessed at baseli

Conditions Studied

Interventions

  • OTHER Saline
  • DRUG Naloxone
  • BEHAVIORAL Mindfulness Meditation
  • BEHAVIORAL Placebo Meditation
  • BEHAVIORAL Slow-Breathing

Study Locations (1)

North Carolina

  • Wake Forest University Health Sciences - Winston-Salem

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2017-03-13
Est. Completion 2017-06-27
Phase Early Phase 1
University of California, San Diego

775 total trials

What the finished NCT03419858 record still lists

NCT03419858 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (80% lower).

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 5 interventions - of which Saline is the first listed.

NCT03419858 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT03419858 about?

NCT03419858 is a clinical study titled "The Role of Opioidergic Systems in Breathing Based Analgesia". The purpose of this psychophysical and pharmacologic study is to determine if slow-breathing induced pain relief is mediated by endogenous opioids in response to intravenous (IV) administration of the opioid antagonist naloxone during noxious heat stimulation. We were also interested in disentanglin...

What is the current status of trial NCT03419858?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 60 participants. The study started on 2017-03-13. Estimated completion is 2017-06-27.

What conditions does trial NCT03419858 study?

This clinical trial studies the following conditions: Pain.

What interventions are being tested in trial NCT03419858?

The interventions under investigation include: Saline (OTHER), Naloxone (DRUG), Mindfulness Meditation (BEHAVIORAL), Placebo Meditation (BEHAVIORAL), Slow-Breathing (BEHAVIORAL).

Who is sponsoring clinical trial NCT03419858?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03419858 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03419858's enrollment target sits among peer trials

60 224th of 374 higher than 134 of 374 other Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03419858, the US trial registry maintained by the National Library of Medicine. NCT03419858 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.